![cdc-update](/sites/default/files/2018-07/cdc-update.jpg)
During the COVID-19 public health emergency, CMS will continue to exercise enforcement discretion under the Clinical Laboratory Improvement Amendments to allow providers to test asymptomatic individuals using certain point-of-care SARS-CoV-2 tests authorized for symptomatic individuals, CMS announced.